Gene · 5352
Papers1,610
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,610
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pediatric Glaucoma-From Screening, Early Detection to Management. | Children (Basel) | 2023 | 36832310 | PubTator, text mining | PubMed |
| microRNAs Associated with Gemcitabine Resistance via EMT, TME, and Drug Metabolism in Pancreatic Cancer. | Cancers (Basel) | 2023 | 36831572 | PubTator, text mining | PubMed |
| From Genetics to Clinical Implications: A Study of 675 Dutch Osteogenesis Imperfecta Patients. | Biomolecules | 2023 | 36830650 | PubTator, text mining | PubMed |
| Transcriptomic Profiling and Pathway Analysis of Mesenchymal Stem Cells Following Low Dose-Rate Radiation Exposure. | Antioxidants (Basel) | 2023 | 36829800 | PubTator, text mining | PubMed |
| Differential response of luminal and basal breast cancer cells to acute and chronic hypoxia. | Breast Cancer Res Treat | 2023 | 36826702 | PubTator, text mining | PubMed |
| The Role of RASSF1C in the Tumor Microenvironment. | Curr Issues Mol Biol | 2023 | 36826019 | PubTator, text mining | PubMed |
| miR-26b Targets CEP135 Gene to Regulate Nasopharyngeal Carcinoma Proliferation and Migration by NF-κB Pathway. | Mol Biotechnol | 2023 | 36820950 | PubTator, text mining | PubMed |
| PLODs: Novel prognostic biomarkers and potential immunotherapy targets for head and neck squamous cell carcinoma. | Heliyon | 2023 | 36820030 | PubTator, text mining | PubMed |
| Osteogenesis Imperfecta: A Case Series and Literature Review. | Cureus | 2023 | 36819366 | PubTator, text mining | PubMed |
| Prognosis and clinical features analysis of EMT-related signature and tumor Immune microenvironment in glioma. | J Med Biochem | 2023 | 36819132 | PubTator, text mining | PubMed |
| Whole-genome sequencing analysis in families with recurrent pregnancy loss: A pilot study. | PLoS One | 2023 | 36800380 | PubTator, text mining | PubMed |
| Integrated Analysis of Transcriptome Changes in Osteoarthritis: Gene Expression, Pathways and Alternative Splicing. | Cartilage | 2023 | 36799242 | PubTator, text mining | PubMed |
| Recent advances in peptide-based therapeutic strategies for breast cancer treatment. | Front Pharmacol | 2023 | 36794282 | PubTator, text mining | PubMed |
| The role of hypoxia on prostate cancer progression and metastasis. | Mol Biol Rep | 2023 | 36787054 | PubTator, text mining | PubMed |
| Computational Investigation of a Series of Small Molecules as Potential Compounds for Lysyl Hydroxylase-2 (LH2) Inhibition. | J Chem Inf Model | 2023 | 36779232 | PubTator, text mining | PubMed |
| RUNX1/CD44 axis regulates the proliferation, migration, and immunotherapy of gliomas: A single-cell sequencing analysis. | Front Immunol | 2023 | 36776876 | PubTator, text mining | PubMed |
| Loss of RhoE Function in Dermatofibroma Promotes Disorganized Dermal Fibroblast Extracellular Matrix and Increased Integrin Activation. | J Invest Dermatol | 2023 | 36774976 | PubTator, text mining | PubMed |
| Glycolysis-Related Gene Analyses Indicate That DEPDC1 Promotes the Malignant Progression of Oral Squamous Cell Carcinoma via the WNT/β-Catenin Signaling Pathway. | Int J Mol Sci | 2023 | 36768316 | PubTator, text mining | PubMed |
| Candidate Genes and Pathways in Cervical Cancer: A Systematic Review and Integrated Bioinformatic Analysis. | Cancers (Basel) | 2023 | 36765810 | PubTator, text mining | PubMed |
| Unusual Suspects: Bone and Cartilage ECM Proteins as Carcinoma Facilitators. | Cancers (Basel) | 2023 | 36765749 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5352/papers?page=12